Mitochondria: It is all about energy
84
TL;DR: In this article , a review of the mitochondrial mechanisms of action that allow for the maintenance of mitochondrial health and the pathways toward dysregulated mechanisms is presented, which is related to metabolic syndrome, neuronal diseases, cancer, cardiovascular and infectious diseases, and inflammatory disorders.
read more
Abstract: Mitochondria play a key role in both health and disease. Their function is not limited to energy production but serves multiple mechanisms varying from iron and calcium homeostasis to the production of hormones and neurotransmitters, such as melatonin. They enable and influence communication at all physical levels through interaction with other organelles, the nucleus, and the outside environment. The literature suggests crosstalk mechanisms between mitochondria and circadian clocks, the gut microbiota, and the immune system. They might even be the hub supporting and integrating activity across all these domains. Hence, they might be the (missing) link in both health and disease. Mitochondrial dysfunction is related to metabolic syndrome, neuronal diseases, cancer, cardiovascular and infectious diseases, and inflammatory disorders. In this regard, diseases such as cancer, Alzheimer’s, Parkinson’s, amyotrophic lateral sclerosis (ALS), chronic fatigue syndrome (CFS), and chronic pain are discussed. This review focuses on understanding the mitochondrial mechanisms of action that allow for the maintenance of mitochondrial health and the pathways toward dysregulated mechanisms. Although mitochondria have allowed us to adapt to changes over the course of evolution, in turn, evolution has shaped mitochondria. Each evolution-based intervention influences mitochondria in its own way. The use of physiological stress triggers tolerance to the stressor, achieving adaptability and resistance. This review describes strategies that could recover mitochondrial functioning in multiple diseases, providing a comprehensive, root-cause-focused, integrative approach to recovering health and treating people suffering from chronic diseases.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Mitochondrial Dynamics in Neurodegenerative Diseases: Unraveling the Role of Fusion and Fission Processes.
Hubert Grel,Damian Woznica,Katarzyna Ratajczak,Ewelina Kalwarczyk,Julia Anchimowicz,W. Świtlik,Piotr Olejnik,P. Zielonka,Magdalena Stobiecka,Slawomir Jakiela +9 more
TL;DR: This review explores how mitochondria fuse and undergo fission, especially in the context of NDs, and discusses the genetic and protein mutations linked to these diseases and how they impact mitochondrial dynamics.
37
Neurodegenerative Disorders: Mechanisms of Degeneration and Therapeutic Approaches with Their Clinical Relevance
Dnyandev Gadhave,Vrashabh V. Sugandhi,Saurav Kumar Jha,Sopan Nangare,Gaurav Gupta,Sachin Kumar Singh,Kamal Dua,Hyunah Cho,Philip M. Hansbro,Keshav Raj Paudel +9 more
TL;DR: Neurodegenerative disorders are characterized by neuronal degeneration and are challenging to treat due to the blood-brain barrier and drug-associated side effects. Understanding the mechanisms underlying neurodegenerative disorders is essential for developing new therapeutic approaches.
31
How Did Antibiotic Growth Promoters Increase Growth and Feed Efficiency in Poultry?
Mariano Enrique Fernández Miyakawa,Natalia Andrea Casanova,Mike Kogut +2 more
TL;DR: Antibiotic growth promoters (AGPs) increase growth and feed efficiency in poultry by modulating the gut microbiome and enhancing mitochondrial function, inducing an adaptive stress response that promotes growth rate and disease tolerance through mitokine production and homeostatic control mechanisms.
16
Dysbiosis of the gut microbiota and its effect on α-synuclein and prion protein misfolding: consequences for neurodegeneration
Nasir Uddin Mahbub,M. Minarul Islam,Hea-Jong Chung +2 more
TL;DR: A thorough analysis explores the complex interactions that exist between the gut microbiota and neurodegenerative illnesses, particularly Parkinson’s disease (PD) and prion disorders and highlights the critical role that the gut microbiota plays in the development of Parkinson’s disease and prion disease.
15
Mitochondrial Dyshomeostasis as an Early Hallmark and a Therapeutic Target in Amyotrophic Lateral Sclerosis
Natalia V. Belosludtseva,Lyudmila A. Matveeva,Konstantin N. Belosludtsev +2 more
TL;DR: Changes in mitochondrial turnover, dynamics, calcium homeostasis, and alterations in mitochondrial transport and functions are summarized to provide in-depth insights into disease progression pathways, which may have a significant impact on current symptomatic therapies and personalized treatment programs for patients with ALS.
14
References
Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
TL;DR: It is suggested that, given consistent observations of microbiota dysbiosis associated with AID and the ability of SCFA and BA to regulate intestinal permeability and inflammation, further mechanistic studies, examining how dietary microbiota modulation can protect against AID, hold considerable potential to tackle increased incidence of AID at the population level.
286
The Crosstalk between the Gut Microbiota and Mitochondria during Exercise
TL;DR: Studies targeting the gut microbiota can be useful for managing mitochondrial related ROS production, pro-inflammatory signals and metabolic limits in endurance athletes.
Stress Induces Endotoxemia and Low-Grade Inflammation by Increasing Barrier Permeability
Karin de Punder,Leo Pruimboom +1 more
TL;DR: It is hypothesized that stresses (defined as homeostatic disturbances) can induce low-grade inflammation by increasing the availability of water, sodium, and energy-rich substances to meet the increased metabolic demand induced by the stressor.
Gut barrier disruption and chronic disease
TL;DR: In this paper , Gut barrier integrity and microbiota dysbiosis may contribute to the development of metabolic, autoimmune, and aging-related disorders, and emerging interventions to improve the Gut Barrier and microbiota composition are described.
278
Historical Perspective: Models of Parkinson's Disease.
TL;DR: The advantages and limitations of the different PD models are discussed and their utility for different research purposes are discussed.
275